We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+71.09%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$591M
AUM Growth
+$160M
Cap. Flow
+$155M
Cap. Flow %
26.27%
Top 10 Hldgs %
18.1%
Holding
732
New
402
Increased
110
Reduced
53
Closed
148

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$11.5M
2
ARM icon
Arm
ARM
+$10.9M
3
AZN icon
AstraZeneca
AZN
+$10M
4
CSCO icon
Cisco
CSCO
+$8.29M
5
ABBV icon
AbbVie
ABBV
+$7.72M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$24.5M
2
NVDA icon
NVIDIA
NVDA
+$16.4M
3
RVMD icon
Revolution Medicines
RVMD
+$15.9M
4
RIO icon
Rio Tinto
RIO
+$11.5M
5
WMT icon
Walmart Inc
WMT
+$9.5M

Sector Composition

Rank Sector Weight
1 Technology 22.62%
2 Industrials 14.98%
3 Healthcare 13.14%
4 Financials 10.95%
5 Materials 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOX icon
326
Fox Class B
FOX
$21.3B
$338K 0.06%
+6,373
New +$368K
STX icon
327
Seagate
STX
$205B
$338K 0.06%
+863
New +$329K
AMP icon
328
Ameriprise Financial
AMP
$47.4B
$336K 0.06%
757
-163
-18% -$78.5K
ULS icon
329
UL Solutions
ULS
$17.4B
$334K 0.06%
+3,900
New +$308K
DLTR icon
330
Dollar Tree
DLTR
$23.5B
$331K 0.06%
3,023
-277
-8% -$33.8K
OCGN icon
331
Ocugen
OCGN
$437M
$327K 0.06%
+180,600
New +$312K
CLX icon
332
Clorox
CLX
$11.6B
$325K 0.06%
+3,138
New +$356K
LXRX icon
333
Lexicon Pharmaceuticals
LXRX
$999M
$324K 0.05%
207,900
+167,600
+416% +$244K
DVA icon
334
DaVita
DVA
$14.9B
$323K 0.05%
2,101
-2,799
-57% -$380K
CL icon
335
Colgate-Palmolive
CL
$73.3B
$322K 0.05%
+3,777
New +$337K
MDGL icon
336
Madrigal Pharmaceuticals
MDGL
$12.4B
$321K 0.05%
+613
New +$293K
URG
337
Ur-Energy
URG
$517M
$319K 0.05%
214,324
-6,876
-3% -$11.2K
EFX icon
338
Equifax
EFX
$20B
$318K 0.05%
+1,767
New +$351K
BG icon
339
Bunge Global
BG
$24B
$317K 0.05%
+2,496
New +$290K
ARW icon
340
Arrow Electronics
ARW
$11.2B
$316K 0.05%
+2,200
New +$302K
AGI icon
341
Alamos Gold
AGI
$12.8B
$315K 0.05%
+7,085
New +$312K
IBOC icon
342
International Bancshares
IBOC
$4.72B
$313K 0.05%
+4,656
New +$323K
DOC icon
343
Healthpeak Properties
DOC
$15.3B
$313K 0.05%
19,063
-14,937
-44% -$256K
CARR icon
344
Carrier Global
CARR
$56.6B
$311K 0.05%
+5,520
New +$327K
AXS icon
345
AXIS Capital
AXS
$8.38B
$310K 0.05%
3,060
-600
-16% -$61.6K
EQIX icon
346
Equinix
EQIX
$101B
$310K 0.05%
+316
New +$281K
OMC icon
347
Omnicom Group
OMC
$22.6B
$304K 0.05%
4,038
-4,062
-50% -$315K
ATHM icon
348
Autohome
ATHM
$2.48B
$304K 0.05%
+17,500
New +$360K
LBRDK icon
349
Liberty Broadband Class C
LBRDK
$4.36B
$303K 0.05%
6,030
– –
SO icon
350
Southern Company
SO
$108B
$303K 0.05%
+3,139
New +$290K
12 13
14
15 16

Similar funds

BBL
Beck Bode LLC Dedham, Massachusetts $591M AUM 37.12% 1-Year Est. Return
BA
Bellwether Advisors Lincoln, Nebraska $590M AUM 35.66% 1-Year Est. Return
DPRC
Deer Park Road Corp Steamboat Springs, Colorado $591M AUM 27.7% 1-Year Est. Return
FL
Fourthstone LLC St Louis, Missouri $590M AUM 29.58% 1-Year Est. Return
MW
Maia Wealth Denver, Colorado $591M AUM 16.31% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
LBIM
Land & Buildings Investment Management Stamford, Connecticut $591M AUM 10.19% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $591M AUM 16.05% 1-Year Est. Return

Catalyst Funds Management's Q1 2026 Portfolio in Review

As of Q1 2026, Catalyst Funds Management held 732 positions worth $591M, up 37% from $431M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Catalyst Funds Management deployed $155M of net new capital in Q1 2026, opening 402 new positions and adding to 110 existing holdings. Its largest new stake was Medline Inc: 259,595 shares worth $11.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Broadcom, an estimated $24.5M trimmed.

  • Catalyst Funds Management's largest Q1 2026 buy was Medline Inc: 259,595 shares worth $11.6M.
  • Catalyst Funds Management added most to AstraZeneca in Q1 2026, an estimated $10M increase.
  • Catalyst Funds Management's biggest Q1 2026 reduction was Broadcom, cutting an estimated $24.5M.
  • Catalyst Funds Management fully exited News Corp Class B in Q1 2026, selling an estimated $5.22M.
  • Catalyst Funds Management's ten largest holdings make up 18% of its $591M portfolio in Q1 2026.
  • Catalyst Funds Management opened 402 new positions and closed 148 in Q1 2026.
  • Catalyst Funds Management's portfolio value rose 37% quarter-over-quarter to $591M.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.